Corlanor (Amgen Inc)
Welcome to the PulseAid listing for the Corlanor drug offered from Amgen Inc. This Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC],Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | ivabradine hydrochloride |
| SUBSTANCE NAME: | IVABRADINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker [EPC],Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2015-04-20 |
| END MARKETING DATE: | 0000-00-00 |
Corlanor HUMAN PRESCRIPTION DRUG Details:
| Item Description | Corlanor from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2015-04-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-800_854d3e43-8545-44f7-958c-b5ddeb2d8798 |
| PRODUCT NDC: | 55513-800 |
| APPLICATION NUMBER: | NDA206143 |
Other IVABRADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
